Colony culture medium without exogenous factor addition and preparation method and application thereof

Through colony culture medium without exogenous factors, using umbilical plasma and exosomes to replace traditional cytokines, the problems of umbilical plasma processing and cell differentiation induction are solved, efficient colony generation and cell identification are achieved, cost reduction and ensuring cell type accuracy.

CN115449510BActive Publication Date: 2024-12-03YINFENG BIOLOGICAL GRP LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202211319999.7
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-10-26
Publication Date
2024-12-03
Estimated Expiration
2042-10-26

AI Technical Summary

Technical Problem

The prior art is difficult to effectively process umbilical plasma after extracting hematopoietic stem cells, maintain the activity of cytokines and use it for colony generation detection, and there is uncertainty as to whether the induced colony cells are granulocytes or monocyte lines.

Method used

Using colony culture medium without exogenous factors, the preparation method includes activating the coagulation reaction, inactivating complement, and removing cold precipitation through the combination of IMDM medium, methylcellulose, umbilical plasma concentrate and umbilical cord mesenchymal exosomes. and ultrafiltration concentrate proteins, replacing cytokines in traditional culture media, are used to induce hematopoietic stem cells to differentiate into granulocytes and monocytes.

Benefits of technology

Achieve colony generation without additional cytokines, maximize the activity of cytokines in plasma, reduce costs, and significantly increase the induction effect and number of colony cells, ensuring the generation of granulocytes and monocyte lines in colonies. .

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN115449510B_ABST
    Figure CN115449510B_ABST
Patent Text Reader

Abstract

The present invention discloses a colony culture medium without the addition of exogenous factors, which is composed of IMDM culture medium, methylcellulose, umbilical plasma concentrate, umbilical cord mesenchymal exosomes and additives; wherein the addition amount of umbilical plasma concentrate is 20% to 40%; the addition amount of umbilical cord mesenchymal stem cell exosomes is 0.5 to 5 μg / ml. The present invention also discloses a preparation method thereof; methylcellulose mother liquor, IMDM culture medium mother liquor, and umbilical plasma concentrate are mixed, and umbilical cord mesenchymal stem cell exosomes and additives are added, and the mixture is mixed to obtain the obtained product. The application of the colony culture medium without the addition of exogenous factors in cultured cells is used in inducing the growth of monocytes, granulocytes, and erythroid cell colonies. The colony culture medium without the addition of exogenous factors of the present invention uses umbilical plasma and exosomes to replace cytokines, and has an obvious colony formation induction effect, does not require the additional addition of cytokines, and greatly reduces the cost.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to a colony culture medium without adding exogenous factors and a preparation method and application thereof, belonging to the technical field of cell culture. Background Art

[0002] Umbilical cord blood hematopoietic stem cells (HSC) have the ability to differentiate into progenitor cells of myeloid cells such as erythrocytes, granulocytes, monocytes-macrophages and megakaryocytes. In vitro semi-solid cell culture colony-forming units are important indicators for evaluating the proliferation and differentiation ability of hematopoietic precursor cells. Under the induction of appropriate cytokines, different directed progenitor cells can produce corresponding colonies, such as CFU-GM, BFU-E, CFU-GEMM, etc.

[0003] The separation of hematopoietic stem cells from umbilical cord blood requires the use of hydroxyethyl starch to sediment red blood cells, and the red blood cells and upper plasma are separated and removed by centrifugal slurrying, and then discarded as medical waste. Umbilical cord plasma contains a variety of cytokines that can support the growth of a variety of hematopoietic progenitor cell colonies, which provides an idea for using discarded umbilical cord plasma to induce colony cell growth and promote colony formation. However, there are a large number of anticoagulants and hydroxyethyl starch in the umbilical cord blood plasma after the hematopoietic stem cells are extracted. How to treat umbilical cord plasma is a technical difficulty. How to maximize the activity of cytokines in umbilical cord plasma during the treatment process, whether the treated umbilical cord plasma can be used for colony formation detection, and whether the induced colony cells are granulocytes or monocytic cells all need to be explored and studied. Summary of the invention

[0004] In view of the above-mentioned prior art, the present invention provides a colony culture medium without the addition of exogenous factors, and a preparation method and application thereof.

[0005] The present invention is achieved through the following technical solutions:

[0006] A colony culture medium without exogenous factor addition is composed of IMDM culture medium, methylcellulose, umbilical cord plasma concentrate, umbilical cord mesenchymal exosomes and additives; wherein the concentration of methylcellulose is 1.3% to 1.5% (w / v, g / ml); the amount of umbilical cord plasma concentrate added is 20% to 40% (volume percentage), preferably 30%; the amount of umbilical cord mesenchymal stem cell exosomes added is 0.5 to 5 μg / ml, preferably 2 μg / ml;

[0007] The specific types and final concentrations of the additives are as follows: GultaMAX additive, 0.9% to 1.1% (v / v); β-mercaptoethanol, 0.25 to 0.35 mol / l; penicillin 90 to 110 U / mL; streptomycin 90 to 110 U / mL.

[0008] The umbilical cord plasma concentrate is prepared by the following method:

[0009] (1) Activate the coagulation reaction, remove fibrinogen, and release factors in platelets: Take umbilical cord plasma, add a mixture of thrombin and calcium chloride, and maintain at room temperature for 25 to 35 minutes;

[0010] The umbilical cord plasma refers to the umbilical cord blood plasma after the hematopoietic stem cells are extracted, which contains a large amount of anticoagulants and hydroxyethyl starch;

[0011] The final concentration of the thrombin is 50 U / mL, and the final concentration of the calcium chloride is 0.5% (mass to volume ratio, unit: g / ml);

[0012] (2) Inactivation of complement: inactivate in a 56°C water bath for 30 min, centrifuge (1000 g for 20 min), and collect the upper plasma;

[0013] (3) Removal of cryoprecipitate: The upper plasma layer was frozen at -20°C for 24 h, then thawed at 4°C and centrifuged (2000 g for 20 min) to remove the cryoprecipitate;

[0014] (4) Ultrafiltration and protein concentration: Use a 20KDa ultrafiltration tube and centrifuge at 4°C for 2 h to collect the concentrate, which is concentrated to 50% of the original volume; filter and sterilize with a 0.45 μm filter membrane to obtain the umbilical cord plasma concentrate enriched with cytokines, which is packaged and stored at -20°C for later use.

[0015] The umbilical cord mesenchymal stem cell exosomes are prepared by the following method: taking the umbilical cord mesenchymal stem cell culture medium, low-speed centrifugation (10000g, 30min) to remove dead cells and cell debris, and then ultra-high-speed centrifugation (100000g, 70min) to collect the exosomes, and adjusting the protein concentration of the exosomes to 500μg / ml.

[0016] The method for preparing the colony culture medium without adding exogenous factors comprises the following steps:

[0017] (I) Preparation of Umbilical Cord Plasma Concentrate:

[0018] (1) Activate the coagulation reaction, remove fibrinogen, and release factors in platelets: Take umbilical cord plasma, add a mixture of thrombin and calcium chloride, and maintain at room temperature for 25 to 35 minutes;

[0019] The umbilical cord plasma refers to the umbilical cord blood plasma after the hematopoietic stem cells are extracted, which contains a large amount of anticoagulants and hydroxyethyl starch;

[0020] The final concentration of the thrombin is 50 U / mL, and the final concentration of the calcium chloride is 0.5% (mass to volume ratio, unit: g / ml);

[0021] (2) Inactivation of complement: inactivate in a 56°C water bath for 30 min, centrifuge (1000 g for 20 min), and collect the upper plasma;

[0022] (3) Removal of cryoprecipitate: The upper plasma layer was frozen at -20°C for 24 h, then thawed at 4°C and centrifuged (2000 g for 20 min) to remove the cryoprecipitate;

[0023] (4) Ultrafiltration and protein concentration: Use a 20KDa ultrafiltration tube and centrifuge at 4°C for 2 h to collect the concentrate, which is concentrated to 50% of the original volume; filter and sterilize with a 0.45 μm filter membrane to obtain the umbilical cord plasma concentrate enriched with cytokines, which is packaged and stored at -20°C for later use.

[0024] (ii) Preparation of umbilical cord mesenchymal stem cell exosomes: The umbilical cord mesenchymal stem cell culture medium was taken and centrifuged at low speed (10000g, 30min) to remove dead cells and cell debris, and then ultrahigh speed centrifugation (100000g, 70min) was performed to collect the exosomes, and the protein concentration of the exosomes was adjusted to 500μg / ml.

[0025] (III) Preparation of colony culture medium without the addition of exogenous factors: Mix methylcellulose mother solution (prepared by conventional method), IMDM culture medium mother solution, and umbilical cord plasma concentrate, add umbilical cord mesenchymal stem cell exosomes and additives (in no particular order), mix well, and obtain the colony culture medium.

[0026] The colony culture medium without exogenous factor addition is used in culturing cells and in inducing the growth of mononuclear cells, granulocytes and erythroid cell colonies.

[0027] The colony culture medium without exogenous factor addition of the present invention uses umbilical cord plasma and exosomes to replace cytokines, has obvious colony formation induction effect, does not need to add additional cytokines, and greatly reduces the cost. The umbilical cord plasma concentrate prepared by the present invention can maximize the enrichment and ensure the activity of cytokines in plasma, can replace the cytokine components that promote colony formation in traditional culture media, and is used to prepare colony culture media to induce hematopoietic stem cells to differentiate into granulocytes and monocytes in vitro.

[0028] The IMDM culture medium and various additives involved in the present invention are all commercial products in the prior art and can be purchased on the market. The IMDM culture medium and IMDM culture medium mother solution can be prepared by yourself. BRIEF DESCRIPTION OF THE DRAWINGS

[0029] Figure 1: A comparative schematic diagram of colony morphology obtained by two culture media, wherein A is a control culture medium (STEMCELL methylcellulose semisolid colony culture medium, item number H4534), and B is a colony culture medium without exogenous factor addition of the present invention (umbilical cord plasma with 2 μg / ml exosome group). The culture medium of the present invention induces the production of granulocyte-monocyte colony CFU-GM, monocyte colony CFU-M, and erythroid burst colony BFU-E.

[0030] Figure 2 : Statistical diagram of the number of colonies obtained using 6 culture media.

[0031] Figure 3 : Schematic diagram of the identification results of colony cells granulocytes and monocytes obtained from two culture media, wherein A, C, and E are colony culture media without exogenous factors added to the present invention (umbilical cord plasma added with 2 μg / ml exosomes), and B, D, and F are control culture media; A and B are Wright-Giemsa staining; C and D are PAS glycogen staining; E and F are CD14-CD15 antigen detection. Monocytes CD14 positive are stained red, granulocytes CD15 positive are green, and CD14 is weakly positive. DETAILED DESCRIPTION

[0032] The present invention will be further described below in conjunction with the embodiments. However, the scope of the present invention is not limited to the following embodiments. It will be appreciated by those skilled in the art that various changes and modifications may be made to the present invention without departing from the spirit and scope of the present invention.

[0033] The instruments, reagents, and materials involved in the following examples, unless otherwise specified, are all conventional instruments, reagents, and materials already available in the prior art and can be obtained through regular commercial channels. The experimental methods and detection methods involved in the following examples, unless otherwise specified, are all conventional experimental methods and detection methods already available in the prior art.

[0034] Example Preparation of colony culture medium without exogenous factor addition

[0035] (I) Preparation of umbilical cord plasma concentrate, the steps are as follows:

[0036] (1) Activate the coagulation reaction, remove fibrinogen, and release factors in platelets: Take umbilical cord plasma, add a mixture of thrombin and calcium chloride, and maintain at room temperature for 30 minutes;

[0037] The umbilical cord plasma refers to the umbilical cord blood plasma after the hematopoietic stem cells are extracted, which contains a large amount of anticoagulants and hydroxyethyl starch;

[0038] The final concentration of the thrombin is 50 U / mL, and the final concentration of the calcium chloride is 0.5%.

[0039] (2) Inactivation of complement: inactivate in a 56°C water bath for 30 min, centrifuge (1000 g for 20 min), and collect the upper plasma;

[0040] (3) Removal of cryoprecipitate: The upper plasma layer was frozen at -20°C for 24 h, then thawed at 4°C and centrifuged (2000 g for 20 min) to remove the cryoprecipitate;

[0041] (4) Ultrafiltration and protein concentration: Use a 20KDa ultrafiltration tube and centrifuge at 4°C for 2 h to collect the concentrate, which is concentrated to 50% of the original volume; filter and sterilize with a 0.45 μm filter membrane to obtain the umbilical cord plasma concentrate enriched with cytokines, which is packaged and stored at -20°C for later use.

[0042] (ii) Preparation of umbilical cord mesenchymal stem cell exosomes: The umbilical cord mesenchymal stem cell culture medium was taken and centrifuged at low speed (10000g, 30min) to remove dead cells and cell debris, and then ultrahigh speed centrifugation (100000g, 70min) was performed to collect the exosomes, and the protein concentration of the exosomes was adjusted to 500μg / ml.

[0043] (III) Preparation of colony culture medium without exogenous factors added:

[0044] Prepare 1L colony culture medium: mix 500ml of methylcellulose mother solution (prepared by conventional method, concentration is 3.0%, g / ml), 200ml of IMDM culture medium mother solution, 300ml of umbilical cord plasma concentrate, add umbilical cord mesenchymal stem cell exosomes and additives (in no particular order), mix well, and the concentration of methylcellulose is 1.5%; the addition amount of umbilical cord mesenchymal stem cell exosomes is 0, 0.5, 1, 2, 5 μg / ml respectively (a total of 5 culture media are prepared for the following experiments).

[0045] The IMDM culture medium mother solution is prepared from IMDM powder using ultrapure water. The concentration of the IMDM culture medium mother solution is 5X. In the colony culture medium, the concentration of the IMDM culture medium is 1X.

[0046] The specific types and final concentrations of the additives are as follows: GultaMAX additive, 1% (v / v); β-mercaptoethanol, 0.3 mol / l; penicillin, 100 U / mL; streptomycin, 100 U / mL.

[0047] Colony culture assay

[0048] (I) The test process, the steps are as follows:

[0049] (1) Obtain umbilical cord blood mononuclear cells by density gradient centrifugation and adjust the final leukocyte concentration to 0.5×10 6 / mL to obtain cell suspension.

[0050] (2) Take 200 μl of colony culture medium (imported reagent control group, umbilical cord plasma group, umbilical cord plasma added with 0.5 μg / ml exosome group, umbilical cord plasma added with 1 μg / ml exosome group, umbilical cord plasma added with 2 μg / ml exosome group, umbilical cord plasma added with 5 μg / ml exosome group, a total of 6 groups of culture medium; the imported reagent is STEMCELL methylcellulose semi-solid colony culture medium, item number H4534; the umbilical cord plasma group, umbilical cord plasma added with 0.5 μg / ml exosome group, umbilical cord plasma added with 1 μg / ml exosome group, umbilical cord plasma added with 2 μg / ml exosome group, umbilical cord plasma added with 5 μg / ml exosome group culture medium, that is, the 5 culture media prepared in the example), add to a 48-well culture plate, add sufficient physiological saline to the outer 24 wells, and maintain the humidity in the culture plate. Place the culture plate in a CO2 incubator and let it stand for 10 minutes to allow the gas in the culture medium to be discharged.

[0051] (3) Pipette 20 μl of the cell suspension and add it to the culture plate so that each well contains 1×10 nuclei. 4 , 3 parallel wells, 5% CO2, 37°C and saturated humidity.

[0052] (4) On the 14th day of culture, the culture plate was removed and the CFU-GM was observed and counted under an inverted microscope.

[0053] (5) Collect colony cells, embed them in paraffin, and slice them.

[0054] (6) Colony cell identification was performed by Giemsa staining, PAS glycogen staining, and CD14 and CD15 immunocytochemical staining.

[0055] (II) Colony identification results

[0056] (1) Colony morphology

[0057] The colony morphology obtained by self-prepared colony culture medium was compared with the consistency of the control group. The results are as follows Figure 1 As shown. CFU-GM granulocyte-monocyte (macrophage) cell-forming units are present in the culture system, and the colonies contain at least 20 to thousands of granulocytes (CFU-G), macrophages (CFU-M) or cells of both lines (CFU-GM). The colony morphology in the culture system conforms to the typical CFU-GM colony morphology, containing one or more cell clusters with dense nuclei. The cells in the monocytic lineage are large cells, irregular in shape, oval to round, and appear to have a granular or gray center. Granulocyte lineage cells are round, bright, much smaller than macrophages, and more uniform in size. Erythroid burst cell colonies (BFU-E) are red. It can be seen from the figure that the cell colonies induced by the addition of umbilical cord plasma and 2μg / ml exosomes are larger, and the cells in the colonies are more vigorous.

[0058] (2) Comparison of colony numbers

[0059] Results of 52 umbilical cord hematopoietic stem cell colony culture Figure 2 As shown, the results showed that there was a difference in the number of colonies obtained by culturing the colony medium with umbilical cord plasma replacement factor and the control imported colony medium. The colonies induced by the mixed umbilical cord plasma colony medium had more cells and grew more vigorously. Compared with the control group, the colony medium with the addition of umbilical cord plasma and exosomes significantly increased the number of colonies induced by the colony medium. The numbers of colonies in the control group, umbilical cord plasma group, umbilical cord plasma group with 0.5μg / ml exosomes, umbilical cord plasma group with 1μg / ml exosomes, umbilical cord plasma group with 2μg / ml exosomes, and umbilical cord plasma group with 5μg / ml exosomes were 5.54±3.55, 6.92±4.12, 7.54±3.90, 8.31±4.16, 9.68±4.94, and 9.52±5.19, respectively.

[0060] (3) Identification of cell types in colonies

[0061] like Figure 3 As shown, the colony cells obtained by self-prepared colony culture medium are mainly granulocytes and monocytes (macrophages), which are consistent with the control group. The characteristics of Wright-Giemsa staining are that the alkaline components in the cells are stained blue, the acidic components are stained red, and the neutral components are not stained. The monocytes have large inclusions, the cytoplasm is stained light blue, and the nucleus is blue; the granulocytes are small and round, the nucleus is stained blue, and the neutrophil cytoplasm is not stained. PAS staining is glycogen staining. There are purple-red glycogen granules with positive reactions in the cytoplasm of granulocytes and macrophages, and the nucleus is blue. D14\CD15 immunofluorescence staining: mCD14 is mainly distributed on the cell surface of monocytes, macrophages and dendritic cells. There is also a small amount of mCD14 on the surface of activated neutrophils. The expression of CD15 in granulocytes is positive. By flow cytometry and double fluorescence staining, the macrophages in the colony had large cell bodies, spread cells, strongly positive CD14 expression, and red cell bodies; CD15 expression in granulocytes was positive, the cell bodies were green, CD14 was weakly positive and red, the cell bodies were small, and the cells were compact.

[0062] The above examples are provided to those skilled in the art to fully disclose and describe how to make and use the claimed embodiments, and are not intended to limit the scope of the disclosure herein. Modifications that are obvious to those skilled in the art will fall within the scope of the appended claims.

Claims

1. A colony culture medium without the addition of exogenous factors, characterized in that: It is composed of IMDM culture medium, methylcellulose, umbilical cord plasma concentrate, umbilical cord mesenchymal exosomes and additives; wherein the concentration of methylcellulose is 1.3% to 1.5%, unit: g / ml; the amount of umbilical cord plasma concentrate added is 20% to 40%, volume percentage; the amount of umbilical cord mesenchymal stem cell exosomes added is 0.5 to 5 μg / ml; The specific types and final concentrations of the additives are as follows: GultaMAX additive, 0.9% to 1.1%, volume ratio; β-mercaptoethanol, 0.25 to 0.35 mol / l; penicillin 90 to 110 U / mL; streptomycin 90 to 110 U / mL; The umbilical cord plasma concentrate is prepared by the following method: (1) Activate the coagulation reaction, remove fibrinogen, and release factors in platelets: Take umbilical cord plasma, add a mixture of thrombin and calcium chloride, and maintain at room temperature for 25 to 35 minutes; (2) Inactivation of complement: inactivate in a 56°C water bath, centrifuge, and take the upper plasma; (3) Removal of cryoprecipitate: The upper plasma layer was frozen at -20°C, then thawed at 4°C, centrifuged, and the cryoprecipitate was removed; (4) Ultrafiltration and protein concentration: Use a 20 KDa ultrafiltration tube and low-temperature ultrafiltration centrifugation to collect the concentrate, which is concentrated to 50% of the original volume; filter and sterilize with a 0.45 μm filter membrane to obtain umbilical cord plasma concentrate enriched with cytokines.

2. The colony culture medium without exogenous factor addition according to claim 1, characterized in that: The final concentration of the thrombin is 50 U / mL, and the final concentration of the calcium chloride is 0.5%.

3. The colony culture medium without exogenous factor addition according to claim 1, characterized in that: The umbilical cord mesenchymal stem cell exosomes are prepared by the following method: taking umbilical cord mesenchymal stem cell culture fluid, centrifuging at low speed to remove dead cells and cell debris, and then collecting exosomes by ultra-high speed centrifugation.

4. The colony culture medium without exogenous factor addition according to claim 3, characterized in that: The umbilical cord mesenchymal stem cell culture medium was centrifuged at 10,000 g for 30 min to remove dead cells and cell debris, and then centrifuged at 100,000 g for 70 min to collect exosomes, and the protein concentration of the exosomes was adjusted to 500 μg / ml.

5. The colony culture medium without exogenous factor addition according to claim 1, characterized in that: The amount of the umbilical cord plasma concentrate added is 30%; the amount of the umbilical cord mesenchymal stem cell exosomes added is 2 μg / ml.

6. The colony culture medium without exogenous factor addition according to claim 1, characterized in that: The specific types and final concentrations of the additives are as follows: GultaMAX additive, 1%; β-mercaptoethanol, 0.3 mol / l; penicillin, 100 U / mL; streptomycin, 100 U / mL.

7. The method for preparing a colony culture medium without adding exogenous factors according to any one of claims 1 to 6, comprising the following steps:

1. Preparation of Umbilical Cord Plasma Concentrate: (1) Activate the coagulation reaction, remove fibrinogen, and release factors in platelets: Take umbilical cord plasma, add a mixture of thrombin and calcium chloride, and maintain at room temperature for 25 to 35 minutes; (2) Inactivation of complement: Inactivate in a 56°C water bath for 30 min, centrifuge, and collect the upper plasma; (3) Removal of cryoprecipitate: The upper plasma layer was frozen at -20°C for 24 h, then thawed at 4°C, centrifuged, and the cryoprecipitate was removed; (4) Ultrafiltration protein concentration: Use a 20 KDa ultrafiltration tube and centrifuge at 4°C for 2 h to collect the concentrate, which is 50% of the original volume; filter and sterilize with a 0.45 μm filter membrane to obtain the umbilical cord plasma concentrate enriched with cytokines for later use; (ii) Preparation of umbilical cord mesenchymal stem cell exosomes: Take the umbilical cord mesenchymal stem cell culture medium, centrifuge at low speed to remove dead cells and cell debris, and then collect the exosomes by ultra-high speed centrifugation, and adjust the protein concentration of the exosomes to 500 μg / ml; (III) Preparation of colony culture medium without adding exogenous factors: Mix methylcellulose mother solution, IMDM culture medium mother solution, and umbilical cord plasma concentrate, add umbilical cord mesenchymal stem cell exosomes and additives, mix well, and obtain the colony culture medium.

8. Use of the colony culture medium without the addition of exogenous factors according to any one of claims 1 to 6 in culturing cells.

9. Use of the colony culture medium without exogenous factor addition according to any one of claims 1 to 6 for inducing colony growth of monocytes, granulocytes and erythroid cells.